| Abstract: | ![]()
A very sensitive liquid chromatographic-mass spectrometric (LC-MS) method has been developed to quantitate iloperidone, 1, and its principal metabolite, 4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-α-methylbenzenemethanol, 2, in human plasma. Iloperidone is currently used in clinical trials for the treatment of psychoses.The analytes were extracted from human plasma using mixed-mode Bond-Elut Cetify cartridges and quantitated using selected-ion monitoring electrospray ionization mass spectrometery (SIM-ES-MS). No interference was observed from endogenous compounds following the extraction of plasma samples from six different human subjects. The limit of quantitation for 1 and 2 was 250 pg/ml of plasma. The standard curves were linear over a working range of 250 pg to 20 ng/ml. Absolute recoveries from plasma ranges from 82 to 101% and 73 to 97% for 1 and 2, respectively. Overall intra-day precision ranged from 0 to 9% and 0.9 to 12.5% for 1 and 2, respectively.The method was found to be rugged and very reliable due to the high specificity of SIM-ES-MS. The results obtained from this study confirm the application of solid-phase extraction combined with SIM-ES-MS in quantitating basic drugs in small quantities in biological extracts. |
